Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (171-180 of 627) with videos related to

Pageof 63
Sort By:
JACC. Heart Failure|December 31, 2016
Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial FibrillationAmbarish Pandey, Sunghee Kim, Curtiss Moore, et al.
Diabetologia|March 15, 2019
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS ProgramDavid R Matthews, Qiang Li, Vlado Perkovic, et al.
Heart (British Cardiac Society)|June 25, 2014
Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromesChristoph Varenhorst, Ulrica Alström, Oscar Ö Braun, et al.
The New England Journal of Medicine|May 24, 2024
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 DiabetesVlado Perkovic, Katherine R Tuttle, Peter Rossing, et al.
Diabetes, Obesity & Metabolism|May 29, 2024
Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trialNavdeep Tangri, Thomas W Ferguson, Ryan J Bamforth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 23, 2026
Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trialBrian Rayner, Kenneth W Mahaffey, Johannes F E Mann, et al.
American Heart Journal|October 8, 2005
Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trialAlejandro Barbagelata, Marcelo F Di Carli, Robert M Califf, et al.
Stroke|April 20, 2021
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-AnalysisZien Zhou, Meg J Jardine, Qiang Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 24, 2020
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS ProgramBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
European Journal of Internal Medicine|February 19, 2026
Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AFGeorge Ntaios, Andreas Goette, Michael G Palazzolo, et al.
Pageof 63

Showing results (171-180 of 627) with videos related to

Sort By:
Pageof 63
JACC. Heart Failure|December 31, 2016
Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial FibrillationAmbarish Pandey, Sunghee Kim, Curtiss Moore, et al.
Diabetologia|March 15, 2019
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS ProgramDavid R Matthews, Qiang Li, Vlado Perkovic, et al.
Heart (British Cardiac Society)|June 25, 2014
Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromesChristoph Varenhorst, Ulrica Alström, Oscar Ö Braun, et al.
The New England Journal of Medicine|May 24, 2024
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 DiabetesVlado Perkovic, Katherine R Tuttle, Peter Rossing, et al.
Diabetes, Obesity & Metabolism|May 29, 2024
Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trialNavdeep Tangri, Thomas W Ferguson, Ryan J Bamforth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 23, 2026
Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trialBrian Rayner, Kenneth W Mahaffey, Johannes F E Mann, et al.
American Heart Journal|October 8, 2005
Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trialAlejandro Barbagelata, Marcelo F Di Carli, Robert M Califf, et al.
Stroke|April 20, 2021
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-AnalysisZien Zhou, Meg J Jardine, Qiang Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 24, 2020
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS ProgramBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
European Journal of Internal Medicine|February 19, 2026
Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AFGeorge Ntaios, Andreas Goette, Michael G Palazzolo, et al.
Pageof 63